HealthEquity (NASDAQ:HQY) Receives Outperform Rating from Barrington Research

HealthEquity (NASDAQ:HQY)‘s stock had its “outperform” rating restated by stock analysts at Barrington Research in a research report issued to clients and investors on Friday, Benzinga reports. They currently have a $105.00 target price on the stock. Barrington Research’s price objective points to a potential upside of 32.39% from the stock’s previous close.

Several other equities analysts have also weighed in on HQY. Wells Fargo & Company raised their price objective on shares of HealthEquity from $107.00 to $110.00 and gave the company an “overweight” rating in a research report on Thursday, June 20th. Bank of America decreased their price target on HealthEquity from $105.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft raised their price objective on HealthEquity from $102.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. KeyCorp increased their price target on HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a report on Wednesday, June 5th. Finally, Raymond James upped their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Friday, June 7th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus target price of $103.83.

HealthEquity Stock Up 0.9 %

NASDAQ HQY traded up $0.72 on Friday, reaching $79.31. The stock had a trading volume of 268,263 shares, compared to its average volume of 621,199. The company has a current ratio of 4.10, a quick ratio of 4.10 and a debt-to-equity ratio of 0.51. HealthEquity has a 1 year low of $61.81 and a 1 year high of $88.26. The business has a 50 day moving average price of $76.11 and a 200 day moving average price of $79.35. The company has a market capitalization of $6.90 billion, a price-to-earnings ratio of 86.73, a P/E/G ratio of 1.19 and a beta of 0.52.

Insider Buying and Selling at HealthEquity

In related news, CEO Jon Kessler sold 32,326 shares of the firm’s stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the sale, the chief executive officer now owns 232,176 shares of the company’s stock, valued at $19,231,138.08. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction on Monday, July 8th. The stock was sold at an average price of $81.89, for a total value of $630,962.45. Following the transaction, the director now directly owns 6,070 shares in the company, valued at approximately $497,072.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon Kessler sold 32,326 shares of the company’s stock in a transaction dated Monday, June 24th. The shares were sold at an average price of $82.83, for a total value of $2,677,562.58. Following the completion of the sale, the chief executive officer now owns 232,176 shares of the company’s stock, valued at approximately $19,231,138.08. The disclosure for this sale can be found here. In the last quarter, insiders sold 75,031 shares of company stock worth $6,103,625. 2.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On HealthEquity

Several institutional investors have recently modified their holdings of HQY. Vanguard Personalized Indexing Management LLC lifted its holdings in HealthEquity by 7.6% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 8,898 shares of the company’s stock worth $590,000 after acquiring an additional 631 shares in the last quarter. Norges Bank acquired a new position in shares of HealthEquity in the fourth quarter valued at approximately $43,482,000. Franklin Resources Inc. increased its position in shares of HealthEquity by 7.0% during the fourth quarter. Franklin Resources Inc. now owns 1,480,655 shares of the company’s stock worth $98,167,000 after acquiring an additional 96,583 shares in the last quarter. Cape Investment Advisory Inc. bought a new stake in HealthEquity in the 4th quarter valued at $27,000. Finally, Hsbc Holdings PLC acquired a new position in HealthEquity in the 4th quarter worth $4,490,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.